Uptrend on the daily chart: above its 200-day average, below its 50-day · 50-day above the 200-day · SuperTrend up since Aug 5 · inside the Ichimoku cloud · RSI 43 · MACD below its signal
| 14.19 | 52-week high | +16.89% |
| 14.13 | Previous month high | +16.39% |
| 13.31 | R3 (classic) | +9.67% |
| 13.22 | Previous week high | +8.90% |
| 12.98 | R2 (classic) | +6.89% |
| 12.68 | R1 (classic) | +4.43% |
| 12.64 | Previous day high | +4.12% |
| 12.34 | Pivot | +1.66% |
| 12.14 | Price now | |
| 12.04 | S1 (classic) | −0.80% |
| 12.01 | Previous day low | −1.11% |
| 12.00 | Previous week low | −1.15% |
| 11.71 | S2 (classic) | −3.57% |
| 11.50 | Previous month low | −5.27% |
| 11.41 | S3 (classic) | −6.03% |
| 3.71 | 52-week low | −69.44% |
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $2.4M | 0.00% | 263.22K | +35% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a AMWL trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Gotlib PhyllisOfficer | Sale at price 13.00 per share. | 6.7K | $86.80K |
| Sep 30, 2026 | Zamansky DmitryChief Technology Officer | Sale at price 13.00 per share. | 8.4K | $109.75K |
| Sep 30, 2026 | Hirschhorn Mark JChief Financial Officer | Sale at price 13.00 per share. | 4.3K | $55.67K |
| Sep 30, 2026 | Mcneice Paul FrancisOfficer | Sale at price 13.00 per share. | 653 | $8.49K |
| Aug 31, 2026 | Gotlib PhyllisOfficer | Sale at price 11.80 per share. | 3.6K | $42.16K |
| Aug 31, 2026 | Hirschhorn Mark JChief Financial Officer | Sale at price 11.80 per share. | 10.8K | $126.86K |
| Aug 31, 2026 | Mcneice Paul FrancisOfficer | Sale at price 11.80 per share. | 112 | $1.32K |
| Jun 30, 2026 | Gotlib PhyllisOfficer | Sale at price 9.33 per share. | 6.7K | $62.30K |
| Jun 30, 2026 | Zamansky DmitryChief Technology Officer | Sale at price 9.33 per share. | 8.5K | $78.93K |
| Jun 30, 2026 | Hirschhorn Mark JChief Financial Officer | Sale at price 9.33 per share. | 4.3K | $40.11K |
| Jun 30, 2026 | Mcneice Paul FrancisOfficer | Sale at price 9.33 per share. | 653 | $6.09K |
| Jun 15, 2026 | Jackson Deborah CDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 15, 2026 | Ross DerekDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 15, 2026 | Schlegel Stephen JDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 15, 2026 | Cosgrove Delos MDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 15, 2026 | Webb Robert ThomasDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 15, 2026 | Goldwasser RivkaDirector | Stock Award(Grant) at price 0.00 per share. | 14.5K | — |
| Jun 10, 2026 | Schlegel Stephen JDirector | Sale at price 8.76 per share. | 9.8K | $85.45K |
| May 31, 2026 | Gotlib PhyllisOfficer | Sale at price 9.74 per share. | 3.6K | $34.80K |
| May 31, 2026 | Hirschhorn Mark JChief Financial Officer | Sale at price 9.74 per share. | 10.8K | $104.81K |
TimeframesUp on the weekly, down on the hourly and daily, mixed on the monthly.
under a falling 21 EMA, 21 under 50
under a falling 21 EMA, 21 under 50
over a rising 21 EMA, 21 over 50
bouncing over the 21 EMA
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.3 | 25.3 | -7.7 | 20.2 | 55.5 | -7.2 | 17.9 | 11.3 | 13.5 | -10.6 | +147.3% | ||
| 2025 | 48.7 | -7.6 | -20.9 | -7.0 | -8.0 | 31.9 | -17.3 | -6.1 | -10.9 | -15.1 | -19.0 | 16.1 | −32.3% |
| 2024 | -29.5 | 2.9 | -24.9 | -37.1 | -16.3 | -23.9 | 23.2 | 3.6 | 14.2 | -3.4 | 4.5 | -24.2 | −75.7% |
| 2023 | 40.3 | -29.7 | -15.4 | -7.2 | 0.9 | -5.0 | 16.7 | -42.0 | -17.6 | 0.0 | 8.5 | 17.3 | −47.3% |
| 2022 | -21.7 | -10.6 | -0.5 | -25.7 | 20.8 | 14.3 | -9.7 | 16.7 | -21.1 | 13.9 | -10.8 | -22.5 | −53.1% |
| 2021 | 39.8 | -30.9 | -29.0 | -11.4 | -19.1 | 1.0 | -7.4 | -8.1 | -14.9 | -1.2 | -27.8 | -7.1 | −76.2% |
| 2020 | -12.9 | 2.8 | -4.6 | −14.5% |
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Buy / hold / sell counts